They showed that BET (bromodomain and extra-terminal domain proteins, consisting of BRD2, BRD3 and BRD4) inhibitors (BETi) may represent small molecules able to prevent DUX4 expression in FSHD muscle cells. The gene discussed is DUX4; the disease is facioscapulohumeral muscular dystrophy.